BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 18207312)

  • 1. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kawakami S; Numao N; Okubo Y; Koga F; Yamamoto S; Saito K; Fujii Y; Yonese J; Masuda H; Kihara K; Fukui I
    Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kattan MW
    Eur Urol; 2008 Sep; 54(3):611. PubMed ID: 18207318
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
    Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Kawakami S; Koga F; Fujii Y; Saito K; Yamamoto S; Tatokoro M; Yonese J; Kageyama Y; Fukui I; Kihara K
    Int J Urol; 2008 Dec; 15(12):1055-60. PubMed ID: 19054174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.
    Suzuki H; Komiya A; Kamiya N; Imamoto T; Kawamura K; Miura J; Suzuki N; Nakatsu H; Hata A; Ichikawa T
    Urology; 2006 Jan; 67(1):131-6. PubMed ID: 16413348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and external validation of an extended 10-core biopsy nomogram.
    Chun FK; Briganti A; Graefen M; Montorsi F; Porter C; Scattoni V; Gallina A; Walz J; Haese A; Steuber T; Erbersdobler A; Schlomm T; Ahyai SA; Currlin E; Valiquette L; Heinzer H; Rigatti P; Huland H; Karakiewicz PI
    Eur Urol; 2007 Aug; 52(2):436-44. PubMed ID: 17010505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
    Chun FK; Graefen M; Briganti A; Gallina A; Hopp J; Kattan MW; Huland H; Karakiewicz PI
    Eur Urol; 2007 May; 51(5):1236-40; discussion 1241-3. PubMed ID: 16945477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population.
    Matsui Y; Utsunomiya N; Ichioka K; Ueda N; Yoshimura K; Terai A; Arai Y
    Jpn J Clin Oncol; 2004 Oct; 34(10):602-7. PubMed ID: 15591458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation and head-to-head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets.
    Utsumi T; Kawamura K; Suzuki H; Kamiya N; Imamoto T; Miura J; Ueda T; Maruoka M; Sekita N; Mikami K; Ichikawa T
    Int J Urol; 2009 Apr; 16(4):416-9. PubMed ID: 19226358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.
    Zlotta AR; Remzi M; Snow PB; Schulman CC; Marberger M; Djavan B
    J Urol; 2003 May; 169(5):1724-8. PubMed ID: 12686818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Dec; 64(6):1165-70. PubMed ID: 15596191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
    Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
    Garzotto M; Hudson RG; Peters L; Hsieh YC; Barrera E; Mori M; Beer TM; Klein T
    Cancer; 2003 Oct; 98(7):1417-22. PubMed ID: 14508828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and external validation of an extended repeat biopsy nomogram.
    Chun FK; Briganti A; Graefen M; Porter C; Montorsi F; Haese A; Scattoni V; Borden L; Steuber T; Salonia A; Schlomm T; Latchemsetty K; Walz J; Kim J; Eichelberg C; Currlin E; Ahyai SA; Erbersdobler A; Valiquette L; Heinzer H; Rigatti P; Huland H; Karakiewicz PI
    J Urol; 2007 Feb; 177(2):510-5. PubMed ID: 17222622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy.
    Lughezzani G; Lazzeri M; Larcher A; Lista G; Scattoni V; Cestari A; Buffi NM; Bini V; Guazzoni G
    J Urol; 2012 Oct; 188(4):1144-50. PubMed ID: 22901589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
    BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nomogram to predict the probability of prostate cancer on repeat biopsy.
    Benecchi L; Pieri AM; Melissari M; Potenzoni M; Pastizzaro CD
    J Urol; 2008 Jul; 180(1):146-9. PubMed ID: 18485383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
    Yanke BV; Gonen M; Scardino PT; Kattan MW
    J Urol; 2005 Feb; 173(2):421-4. PubMed ID: 15643192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Models to predict positive prostate biopsies using the Tyrol screening study.
    Sooriakumaran P; John M; Christos P; Bektic J; Bartsch G; Leung R; Herman M; Scherr D; Tewari A
    Urology; 2011 Oct; 78(4):924-9. PubMed ID: 21840579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
    Chun FK; Karakiewicz PI; Briganti A; Walz J; Kattan MW; Huland H; Graefen M
    BJU Int; 2007 Apr; 99(4):794-800. PubMed ID: 17378842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.